← Feed

Platford Giles Richard

SEC Form 4 insider
President, IBU · TAKEDA PHARMACEUTICAL CO LTD ($TAK)
2 theses · first seen Aug 13, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d111100%-0.1%-0.1%
3d1100%+1.3%+1.3%
1w1100%+5.3%+5.3%
1m1100%+4.9%+4.9%
3m1100%+19.9%+19.9%
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$TAKSEC Form 4bearish
Platford Giles Richard · President, IBU at TAKEDA PHARMACEUTICAL CO LTD · 9d ago1 prior · 0% at 3mo
Sold 55,617 @ $20.90 avg · $1,162,395 · 2026-11-04

Form 4: Platford Giles Richard sold TAK

Platford Giles Richard (President, IBU at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 55,617 shares of TAK at an average $20.90, roughly $1,162,395, in a Form 4 filed 2026-11-05.

Now $21.12as of Nov 12, 4:31 PM ET
View filing on SEC.gov →
$TAKSEC Form 4bearish
Platford Giles Richard · President, IBU at TAKEDA PHARMACEUTICAL CO LTD · 94d ago1 prior · 0% at 3mo
Sold 31,083 @ $17.10 avg · $531,519 · 2026-08-10

Form 4: Platford Giles Richard sold TAK

Platford Giles Richard (President, IBU at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 31,083 shares of TAK at an average $17.10, roughly $531,519, in a Form 4 filed 2026-08-12.

At post $17.41Now $21.12+21.3% since postedas of Nov 12, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m+19.9%
6m—
1y—
View filing on SEC.gov →

End of results.